Candidates must possess a 4-year life science-related degree and 2 years of professional experience working for a life sciences-related company. If the minimum qualifications are met, an invitation to ...

Greater Charlotte is home to a robust, expanding life sciences cluster with a plethora of international firms. Assets in the region span medtech/medical device development and manufacturing, ...

This event brings together the next generation of STEM leaders for an evening of meaningful connection, career discovery and insight. Join fellow interns and engage with professionals across the ...

Join Innovate Carolina’s Office of Technology Commercialization for its 2025 Celebration of Inventorship, an evening dedicated to recognizing UNC’s distinguished inventors. This event will feature ...

The U.S. Food and Drug Administration (FDA) has accepted Durham-based BioCryst Pharmaceuticals’ application to expand the use of ORLADEYO (berotralstat) to treat children ages 2 to 11 with a rare ...

If you're on the job hunt, you have probably been asked to describe your background and what you are looking for. To perfect that elevator pitch, you must first figure out the bigger answers for ...

The Translational Research Grant (TRG) program funds research projects that explore commercial applications or initiate the early commercial development of university-held life sciences inventions.

An online marketplace connecting life sciences companies with workforce talent in North Carolina has been retooled to better serve employers and job seekers throughout the state. The North Carolina ...

Following a regulatory setback last year, Satsuma Pharmaceuticals Inc. has won approval for its nasal powder migraine treatment device from the U.S. Food and Drug Administration. Satsuma, a unit of a ...

Join us for the inaugural panel event of the Operational Excellence Network of NC. This event will cover how a continuous improvement (CI) mindset drives innovation, efficiency, and resilience across ...

Durham-based Atsena Therapeutics has received Regenerative Medicine Advanced Therapy (RMAT) designation from the U.S. Food and Drug Administration (FDA) for ATSN-201, its gene therapy product for the ...